KRAS and breast neoplasm: Although little is known about the precise role of KRAS mutations in progression of BC, it is well-established that PI3K/AKT/PTEN pathway is under control of KRAS activity and that abnormal activation of this oncogenic pathway promotes breast tumor growth and invasion [15,16].